Year: 2024
Type: article
Study design: Case Report
Abstract: A healthy 60-year-old female patient, with a history of Quervain's Syndrome, presented with corticosteroid-induced dermatoporosis after receiving intra-articular corticosteroid injections. She experienced skin fragility and aesthetic discomfort due to dermal atrophy and a violaceous macule at the injection site. Treatment with calcium hydroxyapatite (CaHA) biostimulator was initiated, resulting in significant improvements in skin quality and pigmentation. Following two sessions, the patient reported enhanced self-esteem and satisfaction with the treatment outcomes. This case underscores the potential of CaHA as an effective therapeutic option for managing early stages of dermatoporosis.
Authors: Fernanda Cassain, Marisa Gonzaga, Jeovana Soares, Renata Viana, Márcio Serra
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4404590139